A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies.

PHASE3CompletedINTERVENTIONAL

Enrollment

323

Participants

Timeline

Start Date

September 6, 2022

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions

Peripheral Sensory Neuropathy of Different Etiologies

Interventions

DRUG

Vitamin B combination tablet

Once daily, with some liquid with or after a meal

DRUG

Placebo Tablet

Once daily, with some liquid with or after a meal

Trial Locations (1)

RM Pharma Specialists S.A. de C.V., Mexico City

All Listed Sponsors

lead

Procter and Gamble

INDUSTRY